All Stories

  1. Persistent symptoms, quality of life, and risk factors in long COVID: a cross-sectional study of hospitalized patients in Brazil
  2. WGS-Based Lineage and Antimicrobial Resistance Pattern of Salmonella Typhimurium Isolated during 2000–2017 in Peru
  3. Factors associated with nonadherence to the use of coumarin derivatives or direct oral anticoagulants: A systematic review of observational studies
  4. Tracking the turnover of SARS-CoV-2 VOCs Gamma to Delta in a Brazilian state (Minas Gerais) with a high-vaccination status
  5. Spatial and temporal fluctuations in COVID-19 fatality rates in Brazilian hospitals
  6. Blockade of interleukin seventeen (IL-17A) with secukinumab in hospitalized COVID-19 patients – the BISHOP study
  7. Delta Variant of SARS-CoV-2 Replacement in Brazil: A National Epidemiologic Surveillance Program
  8. IFITM3, FURIN, ACE1, and TNF-α Genetic Association With COVID-19 Outcomes: Systematic Review and Meta-Analysis
  9. Seroprevalence, Prevalence, and Genomic Surveillance: Monitoring the Initial Phases of the SARS-CoV-2 Pandemic in Betim, Brazil
  10. Cannabinoid receptor gene polymorphisms and cognitive performance in patients with schizophrenia and controls
  11. Seroprevalence, prevalence, and genomic surveillance: monitoring the initial phases of the SARS-CoV-2 pandemic in Betim, Brazil
  12. Systematic review of host genetic association with Covid‐19 prognosis and susceptibility: What have we learned in 2020?
  13. Blockade of Interleukin Seventeen (IL-17A) with Secukinumab in Hospitalized COVID-19 patients – the BISHOP study
  14. Genetic association of the PERIOD3 (PER3) Clock gene with extreme obesity
  15. Dengue virus infection induces inflammation and oxidative stress on the heart
  16. Epidemic Spread of SARS-CoV-2 Lineage B.1.1.7 in Brazil
  17. Association between ACE2 and TMPRSS2 nasopharyngeal expression and COVID-19 respiratory distress
  18. Field and classroom initiatives for portable sequence-based monitoring of dengue virus in Brazil
  19. Common Dysregulation of Innate Immunity Pathways in Human Primary Astrocytes Infected With Chikungunya, Mayaro, Oropouche, and Zika Viruses
  20. Biosafety in Dental Health Care During Covid-19 Pandemic: A Longitudinal Study
  21. Effects of aging on DNA hydroxymethylation and methylation in human dental follicles
  22. Evolution and epidemic spread of SARS-CoV-2 in Brazil
  23. Early postnatal l-Dopa treatment causes behavioral alterations in female vs. male young adult Swiss mice
  24. Multi-ancestry GWAS of the electrocardiographic PR interval identifies 202 loci underlying cardiac conduction
  25. Behavioral plasticity and gene regulation in the brain during an intermittent ethanol exposure in adult zebrafish population
  26. Impairment of motor but not anxiety‐like behavior caused by the increase of dopamine during development is sustained in zebrafish larvae at later stages
  27. Disentangling the Environmental Factors That Shape Genetic and Phenotypic Leaf Trait Variation in the Tree Qualea grandiflora Across the Brazilian Savanna
  28. Non-genetic factors and polymorphisms in genes CYP2C9 and VKORC1: predictive algorithms for TTR in Brazilian patients on warfarin
  29. Algorithm for predicting low maintenance doses of warfarin using age and polymorphisms in genes CYP2C9 and VKORC1 in Brazilian subjects
  30. Multi-ancestry GWAS of the electrocardiographic PR interval identifies 210 loci underlying cardiac conduction
  31. Protocol of a clinical trial study involving educational intervention in patients treated with warfarin
  32. Inhibition of Tityus serrulatus venom hyaluronidase affects venom biodistribution
  33. Variation of rs3754689 at lactase gene and inhibitors in admixed Brazilian patients with hemophilia A
  34. Hyaluronidase: the spreading factor of Tityus serrulatus venom
  35. Definition of Late Onset Alzheimer’s Disease and Anticipation Effect of Genome-Wide Significant Risk Variants: Pilot Study of the APOE e4 Allele
  36. Characterization of MicroRNA Expression Profiles and Identification of Potential Biomarkers in Leprosy
  37. Does cell phone use increase the chances of parotid gland tumor development? A systematic review and meta-analysis
  38. DNA damage after chronic oxytocin administration in rats: a safety yellow light?
  39. Cohesin subunits,STAG1andSTAG2, and cohesin regulatory factor,PDS5b, in oral squamous cells carcinomas
  40. Cell phone use is associated with an inflammatory cytokine profile of parotid gland saliva
  41. Association betweenDCHS2gene and mild cognitive impairment and Alzheimer's disease in an elderly Brazilian sample
  42. Meta-analysis of dopamine receptor D1 rs4532 polymorphism and susceptibility to antipsychotic treatment response
  43. Effects of primaquine and chloroquine on oxidative stress parameters in rats
  44. Lip cancer and pre-cancerous lesions harbor TP53 mutations, exhibit allelic loss at 9p, 9q, and 17p, but no BRAFV600E mutations
  45. Lewy Body Dementia and Frontotemporal Dementia
  46. Lack of association between dopamine-β hydroxylase gene and a history of suicide attempt in schizophrenia
  47. Investigation of melanocortin system gene variants in antipsychotic-induced weight gain
  48. The role of tyrosine hydroxylase gene variants in suicide attempt in schizophrenia
  49. Behavioral metabolomics analysis identifies novel neurochemical signatures in methamphetamine sensitization
  50. Analysis of CpG SNPs in 34 genes: Association test with suicide attempt in schizophrenia
  51. Chronic exposure to cigarette smoke during gestation results in altered cholinesterase enzyme activity and behavioral deficits in adult rat offspring: Potential relevance to schizophrenia
  52. Finite mixture regression model analysis on antipsychotics induced weight gain: Investigation of the role of the serotonergic genes
  53. Genotype-Based Ancestral Background Consistently Predicts Efficacy and Side Effects across Treatments in CATIE and STAR*D
  54. Genome-wide association study of patient-rated and clinician-rated global impression of severity during antipsychotic treatment
  55. Effect of cigarette smoke exposure in the behavioral changes induced by ketamine
  56. The role of brain-derived neurotrophic factor (BDNF) gene variants in antipsychotic response and antipsychotic-induced weight gain
  57. Sociodemographic characteristics, clinical factors, and genetic polymorphisms associated with Alzheimer's disease
  58. Genome-wide pharmacogenomic study of citalopram-induced side effects in STAR*D
  59. Association study of GRIK1 gene polymorphisms in schizophrenia: case-control and family-based studies
  60. Association study between variants of AMP-activated protein kinase catalytic and regulatory subunit genes with antipsychotic-induced weight gain
  61. Dopamine D4 and D5 receptor gene variant effects on clozapine response in schizophrenia: Replication and exploration
  62. Genetic association study between antipsychotic-induced weight gain and the melanocortin-4 receptor gene
  63. Admixture analysis of Age at Onset in Schizophrenia: Genetic Association Study of 45 candidate loci
  64. Botulinum Toxin for Vaginismus Treatment
  65. Genetic Underpinnings of Neuroticism: A Replication Study
  66. Pharmacogenomic study of side-effects for antidepressant treatment options in STAR*D
  67. Genetic interactions in the adrenergic system genes: analysis of antipsychotic-induced weight gain
  68. Parent of origin effect and allelic expression imbalance of the serotonin transporter in bipolar disorder and suicidal behaviour
  69. Are serotonin 3A and 3B receptor genes associated with suicidal behavior in schizophrenia subjects?
  70. Gene–gene interaction analyses between NMDA receptor subunit and dopamine receptor gene variants and clozapine response
  71. Lack of association of NALCN genetic variants with schizophrenia
  72. Prolactin as a biomarker for treatment response and tardive dyskinesia in schizophrenia subjects: old thoughts revisited from a genetic perspective
  73. The 2nd Schizophrenia International Research Society Conference, 10–14 April 2010, Florence, Italy: Summaries of oral sessions
  74. Polymorphisms of the HTR2C gene and antipsychotic-induced weight gain: an update and meta-analysis
  75. Association study of the GSK-3B gene with tardive dyskinesia in European Caucasians
  76. Influence of neurexin 1 (NRXN1) polymorphisms in clozapine response
  77. Downregulation of the cAMP/PKA Pathway in PC12 Cells Overexpressing NCS-1
  78. Age at onset in Canadian Schizophrenia patients: Admixture analysis
  79. Association of functional variants in the dopamine D2-like receptors with risk for gambling behaviour in healthy Caucasian subjects
  80. Phosphodiesterase 4B genetic variants are not associated with antipsychotic-induced tardive dyskinesia
  81. Parent of origin effect and differential allelic expression of BDNF Val66Met in suicidal behaviour
  82. Systematic analysis of dopamine receptor genes (DRD1–DRD5) in antipsychotic-induced weight gain
  83. Cocaine and amphetamine regulated transcript (CART) gene in the comorbidity of schizophrenia with alcohol use disorders and nicotine dependence
  84. Genetic association of the GDNF alpha-receptor genes with schizophrenia and clozapine response
  85. Variants in the oxytocin gene and risk for schizophrenia
  86. Evaluation of light/dark cycle in anxiety- and depressive-like behaviors after regular treatment with methylphenidate hydrochloride in rats of different ages
  87. Inhibitory avoidance task does not change NCS-1 level in rat brain
  88. Schizophrenia severity and clozapine treatment outcome association with oxytocinergic genes
  89. Lack of effects of typical and atypical antipsychotics in DARPP-32 and NCS-1 levels in PC12 cells overexpressing NCS-1
  90. Glial cell line-derived neurotrophic factor receptor alpha 2 (GFRA2) gene is associated with tardive dyskinesia
  91. Influence of serotonin 3A and 3B receptor genes on clozapine treatment response in schizophrenia
  92. Diurnal differences in memory and learning in young and adult rats treated with methylphenidate
  93. Pharmacogenetics of antipsychotic treatment response and side effects
  94. A Common Polymorphism in the Cannabinoid Receptor 1 (CNR1) Gene is Associated with Antipsychotic-Induced Weight Gain in Schizophrenia
  95. Genetic Studies in Treatment-Resistant Schizophrenia
  96. Lack of association between HTR4 gene polymorphisms and schizophrenia in case–control and family-based samples
  97. “GSK3B and schizophrenia: a case not closed” reply
  98. Lack of association of GPX1 and MnSOD genes with symptom severity and response to clozapine treatment in schizophrenia subjects
  99. Chronic Methylphenidate-Effects Over Circadian Cycle of Young and Adult Rats Submitted to Open-Field and Object Recognition Tests
  100. Progress in Genetic Studies of Schizophrenia
  101. Association of the α2A adrenergic receptor -1291C/G polymorphism and antipsychotic-induced weight gain in European–Americans
  102. Pharmacogenetics of anxiolytic drugs
  103. MDR1 gene in tardive dyskinesia scale scores: Comparison of strategies for quantitative trait haplotype analysis
  104. Corrigendum to “Summary of the 1st Schizophrenia International Research Society Conference oral sessions, Venice, Italy, June 21–25, 2008: The rapporteur reports”
  105. Glutathione S-Transferase Variants in a Brazilian Population
  106. Association of antipsychotic induced weight gain and body mass index with GNB3 gene: A meta-analysis
  107. Cerebral DARPP‐32 expression after methylphenidate administration in young and adult rats
  108. Summary of the 1st Schizophrenia International Research Society Conference oral sessions, Venice, Italy, June 21–25, 2008: The rapporteur reports
  109. Reduced prefrontal cortex DARPP-32 mRNA in completed suicide victims with schizophrenia
  110. Methylphenidate alters NCS-1 expression in rat brain
  111. GENETIC ASSOCIATION ANALYSIS OF THE GFR ALPHA GENES WITH SCHIZOPHRENIA AND CLOZAPINE RESPONSE
  112. Association study of GSK3 gene polymorphisms with schizophrenia and clozapine response
  113. DARPP-32 Expression in Rat Brain After an Inhibitory Avoidance Task
  114. Is DARPP-32 a potential therapeutic target?
  115. DARPP-32 expression in rat brain after electroconvulsive stimulation
  116. NCS-1 Expression in Rat Brain after Electroconvulsive Stimulation
  117. Darpp32